Further evidence that thromboxane exacerbates arrhythmias: Effects of UK38485 during coronary artery occlusion and reperfusion in anaesthetized greyhounds
- 1 July 1984
- journal article
- research article
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 16 (7) , 633-641
- https://doi.org/10.1016/s0022-2828(84)80627-6
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Lack of thromboxane A2 involvement in the arrhythmias occurring during acute myocardial ischemia in dogsBasic Research in Cardiology, 1982
- Elevation of thromboxane B2 levels in patients with classic and variant angina Pectoris.Circulation, 1981
- Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmiasNature, 1981
- Thromboxane A2in Vasotonic Angina PectorisNew England Journal of Medicine, 1981
- Failure of antiarrhythmic drugs to prevent experimental reperfusion ventricular fibrillation.Circulation, 1981
- Effects of prostaglandins and thromboxane A2 on the coronary circulation of adult dogs and puppiesEuropean Journal of Pharmacology, 1980
- Influence of thromboxane inhibition on the severity of myocardial ischemia in catsCanadian Journal of Physiology and Pharmacology, 1980
- Experimental ischemic heart disease—Effects of synthetic thromboxane A2Experimental and Molecular Pathology, 1979
- Coronary Arterial Smooth Muscle Contraction by a Substance Released from Platelets: Evidence That It Is Thromboxane A 2Science, 1976
- Differing mechanisms for ventricular vulnerability during coronary artery occlusion and releaseAmerican Heart Journal, 1976